Last updated: May 2, 2026
AU2017201628 (Australia): Scope, Claims, and Patent Landscape
AU2017201628 is an Australian patent publication that sits in a crowded global field defined by (1) the underlying active pharmaceutical ingredient (API) and (2) the specific salt, polymorph, formulation, and method-of-use angles claimed in the document. Without the patent text (claims, specification, and claim dependencies), no complete and accurate mapping of scope, claim construction, or landscape position can be produced.
What does AU2017201628 claim in Australia?
No complete response can be generated from the information provided. A scope-and-claims analysis requires the exact claim set (independent and dependent claims), including the claim language that defines:
- the API (and its identifiers)
- the salt/form of the API (if claimed)
- the formulation composition and percentages (if claimed)
- particle size, polymorph, solvates/hydrates, and other physical parameters (if claimed)
- the method of treatment and patient/indication constraints (if claimed)
- any dosing regimen, administration route, or treatment criteria (if claimed)
- prior-art limiting features introduced via dependencies (which control claim breadth)
What is the likely claim breadth (practitioner view) if the API/formulation is known?
No complete response can be generated. Claim breadth in Australia depends on how the claims are drafted (Markush language, genus vs species, product-by-process, method-of-use specificity, and whether the claims include functional limitations or only structural limitations). Those elements are text-dependent and must be quoted from AU2017201628.
Where does AU2017201628 sit in the global patent landscape?
No complete response can be generated. A landscape placement requires at least:
- the priority chain (earliest priority date(s))
- the parent/grant family members (EP/US/WO) and their numbers
- claim-set differences across family members (often material for litigation and regulatory exclusivity)
- enforcement status in relevant jurisdictions (granted/pending, opposition outcomes)
Those facts must be taken from the publication record and the patent family documents.
Why a complete landscape read is impossible without the patent record
A proper landscape and claim-scope deliverable is document-driven. For AU2017201628, the following are mandatory inputs that were not included in the prompt:
- the claims section (verbatim)
- the description sections that define terms used in claims (especially drug forms and dosing terms)
- the bibliographic record (publication and priority data)
- the family tree (WO/EP/US/JP/CN equivalents)
- legal status (grant or lapse) where relevant to Australia
Because those inputs are absent, any attempt to “fill in” scope, claim features, or landscape relationships would be speculative and would not meet a high-stakes analysis standard.
Key Takeaways
- A complete scope and claims analysis for AU2017201628 requires the verbatim claim set and bibliographic data.
- Landscape positioning requires the priority chain, family membership, and status in key jurisdictions.
- The provided prompt does not contain the AU2017201628 text, family data, or claim language needed for an accurate, citeable analysis.
FAQs
1) What document elements are required to analyze claim scope for an Australian patent?
The independent claim(s), dependent claim dependencies, definitions used in the specification, and the priority/family data.
2) How does claim drafting style change the effective scope in Australia?
Genus versus species drafting, Markush language, physical parameter recitals, functional limitations, and method-of-use specificity materially affect the effective scope.
3) What counts as “landscape” for a drug patent?
The global family (WO/EP/US equivalents), nearby patent clusters (formulation, polymorph, method-of-use), and regulatory exclusivity interactions (data exclusivity, patent linkage where applicable).
4) Can landscape conclusions be drawn without the patent claims?
Not reliably. Landscape conclusions that rely on the claimed subject matter must match the actual claim language.
5) What is the fastest path to a definitive AU patent landscape read?
A document-first approach: claims and specification text plus a validated family tree.
References (APA)
No sources were provided or retrievable within the information given, so no inline citations can be produced.
